The Potential Mechanisms of Ochratoxin A in Prostate Cancer Development: An Integrated Study Combining Network

Hong Cai1, Dandan Shen1, Xiangjun Hu1

  • 1College of Clinical Medicine, Jiangxi University of Chinese Medicine, Wanli Campus, Nanchang 330004, China.

Toxins
|August 27, 2025
PubMed

Insights

Ochratoxin A (OTA), a food contaminant, may contribute to prostate cancer. This study used computational methods to identify key molecular targets and pathways involved in OTA-induced cancer progression.

Area of Science:

  • Toxicology
  • Oncology
  • Computational Biology

Background:

  • Ochratoxin A (OTA) is a common food contaminant with suspected links to prostate cancer.
  • The exact mechanisms by which OTA influences prostate cancer development are not fully understood.

Purpose of the Study:

  • To elucidate the role of Ochratoxin A in prostate cancer pathogenesis.
  • To identify key molecular targets and pathways affected by OTA exposure.

Main Methods:

  • Integrated network toxicology, machine learning, and molecular docking.
  • Identified 364 potential OTA targets in prostate cancer.
  • Utilized machine learning to prioritize five critical molecular targets: ESR1, TP53, TNF, INS, and EGFR.

Main Results:

  • OTA interacts with a significant number of prostate cancer-related targets.
  • Five key targets (ESR1, TP53, TNF, INS, EGFR) were prioritized by machine learning.
  • Functional enrichment analysis suggested OTA disrupts endocrine function, activates oncogenic pathways, alters metabolism, and modulates the tumor microenvironment.

Conclusions:

  • OTA may promote prostate cancer progression through multiple molecular mechanisms.
  • The identified key targets and pathways provide a basis for understanding OTA's carcinogenic potential.
  • This study offers insights into the complex relationship between dietary contaminants and cancer development.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.2K